Notice of Application - 2011
[Federal Register Volume 76, Number 250 (Thursday, December 29, 2011)]
[Notices]
[Page 81979]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33421]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on October 10, 2011, Norac Inc.,
405 S. Motor Avenue, Azusa, California 91702-3232, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Methamphetamine (1105) |
II |
| Pentobarbital (2270) |
II |
| Nabilone (7379) |
II |
With regard to Gamma Hydroxybutyric Acid (2010),
Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the
company manufactures these controlled substances in bulk solely for
distribution within the United States to customers engaged in dosage-
form manufacturing.
With regard to Nabilone (7379), the company presently manufactures
a small amount of this controlled substance in bulk solely to conduct
manufacturing internal process development. It is the company's
intention that, when the manufacturing process is refined to the point
that its Nabilone bulk product is available for commercial use, the
company will export the controlled substance in bulk solely to
customers engaged in dosage-form manufacturing outside the United
States. The company is aware of the requirement to obtain a DEA
registration as an exporter to conduct this activity.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than February 27, 2012.
Dated: December 20, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-33421 Filed 12-28-11; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
